A new combination of drugs is found effective in reducing relapse rate in patients suffering from severe Multiple Sclerosis by 90%, a new study reveals. The new treatment, which is pioneered by British scientists at the Liverpool's Walton Centre for Neurology, involves the use of Mitoxantrone, a common anti-cancer drug and Copaxone, a Multiple Sclerosis anti-attack drug.

There is actually no cure for Multiple Sclerosis, but drugs can lessen attacks and relapses and the combination of the two drugs is the most powerful treatment, so far. One aggressive MS patient named Karen Ayres who underwent the experimental treatment said she used to be totally paralyzed and unable to move around without her wheelchair but after the treatment, she has successfully regained mobility. In fact, she’s now taking up doctoral studies.

Multiple Sclerosis is a chronic degenerative disorder of the nervous system characterized by weakness of the muscles, fatigue, poor vision, speech defects, and paralysis. It occurs mostly to young adults and is probably caused by certain genetic and environmental factors (such as a virus).